Log In
Print
BCIQ
Print
Print this Print this
 

HIV vaccine

  Manage Alerts
Collapse Summary General Information
Company PaxVax Inc.
DescriptionAdenoviral-based oral combination HIV vaccine composed of Ad4-env Clade C to induce an effective antibody response and Ad4-mGag to induce broadly reactive T cell response
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsVaccinate against HIV
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today